...
首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Hematologic, immunologic reconstitution, and outcome of 342 autologous peripheral blood stem cell transplantations after cryopreservation in a -80??C mechanical freezer and preserved less than 6 months
【24h】

Hematologic, immunologic reconstitution, and outcome of 342 autologous peripheral blood stem cell transplantations after cryopreservation in a -80??C mechanical freezer and preserved less than 6 months

机译:在-80?C机械冰箱中冷冻保存并保存不到6个月后,进行342例自体外周血干细胞移植的血液学,免疫学重建和结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Controlled-rate freezing and storage in nitrogen is the standard technique for cryopreservation of peripheral hematopoietic progenitor cells (PHPCs) but presents high cost and dimethyl sulfoxide (DMSO) toxicity. Cryopreservation at -80??C, by uncontrolled rate freezing with only 3.5% DMSO, preserves the functional capacities of PHPCs, produces successful engraftment, and reduces toxicity during infusion. Study Desing and Methods: Long-term hematopoietic and immunologic reconstitution for 342 autografts (311 adults, 31 children) after PHPCs were cryopreserved at -80??C was studied at 3, 6, and 12 months. The median (range) storage time of PHPCs cryopreserved was 1.7 (0.1-5.99) months. Results: Hemoglobin (Hb), white blood cells, and platelets (PLTs) reach normal values to trilineage at 12 months for 39% patients. Multivariate analysis shows a significant impact on CD34+ infused and on conditioning regimen for PLTs. Hb was influenced by growth factor administration at 3 months. Long-term recovery is also highly dependent on blood counts (Hb, PLT, and neutrophil) at start of high-dose chemotherapy. Only 43% of patients had reached normal lymphocyte values at 12 months after transplant, and a profound CD4+ T-lymphocyte deficit remained, as others reported. Conclusion: Transplantation with PHPCs cryopreserved at -80??C for no more than 6 months is satisfactory for long-term hematopoietic and immunologic reconstitution, even if a profound CD4+ T lymphocyte deficit persists at 1 year. This easier and cheaper cryopreservation method also leads to successful engraftment. ? 2012 American Association of Blood Banks.
机译:背景:氮气中受控速率的冷冻和储存是冷冻保存外周血造血祖细胞(PHPC)的标准技术,但存在高成本和二甲基亚砜(DMSO)毒性。通过仅用3.5%DMSO进行不受控制的冷冻速率,可在-80℃进行低温保存,保留了PHPC的功能能力,成功植入并降低了输注过程中的毒性。研究目的和方法:研究了在3.8、6和12个月时将PHPC冷冻保存在-80℃下后,对342例自体移植物(311名成人,31名儿童)的长期造血和免疫重建。冷冻保存的PHPC的中位(范围)存储时间为1.7(0.1-5.99)个月。结果:39%的患者在12个月时血红蛋白(Hb),白细胞和血小板(PLT)达到三系谱的正常值。多变量分析显示对注入的CD34 +和PLT的调理方案有重大影响。血红蛋白在3个月时受到生长因子管理的影响。大剂量化疗开始时,长期恢复还高度依赖于血细胞计数(Hb,PLT和中性粒细胞)。正如其他人所报道的那样,仅43%的患者在移植后12个月达到了正常的淋巴细胞值,并且仍然存在严重的CD4 + T淋巴细胞缺乏症。结论:即使在1年后仍存在严重的CD4 + T淋巴细胞缺乏症,PHPCs于-80℃低温保存不超过6个月的移植仍可长期造血和免疫重建。这种更容易和更便宜的冷冻保存方法还可以成功植入。 ? 2012年美国血库协会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号